Predicting gait and timed up and go time using foot-tapping test and accelerometer
Physiological Measurement · 31.08.2026 · 47 (8) · 085004
DOI: 10.1088/1361-6579/ae8ca9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Measurement, online erschienen am 11.08.2026. Verfasst von Shamim Noroozi und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering, University of British Columbia Okanagan, Kelowna, BC, Canada. Hauptthemen laut MEDLINE: Accelerometry, Foot, Gait. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Objective. Gait and the timed up and go (TUG) time are the two tests that are widely used to assess functional mobility; however, their administration requires space and trained personnel, limiting feasibility for routine assessment. A brief, seated foot-tapping test may offer a practical alternative. This study examined whether accelerometer-derived features from unilateral foot-tapping can predict gait and TUG times across the adult lifespan. Approach. Seventy-eight adults aged 19–95 years (58 older adults: 80.25 ± 8.2 yrs; 20 young-to-midlife: 32.2 ± 14.1 yrs) performed 30-second unilateral foot-tapping trials with the dominant and nondominant foot. Time, frequency, and time–frequency domain features were extracted from triaxial accelerometer signals. Least absolute shrinkage and selection operator (LASSO) and Random Forest regression models were trained within a nested 5-fold cross-validation to predict gait and TUG. Main Results. Significant correlations ( p < 0.05) were observed between foot-tapping features and both outcomes, with coefficients ranging from −0.5 to −0.35 for gait time and −0.6 to 0.55 for TUG time. Most of the corrected features were derived from time–frequency domain (∼65%) and time domain (∼35%), with the strongest associations observed for tapping rate, inter-tap variability, and variability in instantaneous tapping energy across trials. LASSO achieved lower average root mean square error (RMSE) than Random Forest for dominant-foot gait time (0.88 ± 0.23 s vs. 0.93 ± 0.21 s) and TUG time (2.76 ± 0.60 s vs. 2.88 ± 0.65 s), and for nondominant-foot gait time (0.89 ± 0.20 s vs 0.90 ± 0.20 s), and TUG time (2.93 ± 0.54 s vs. 2.96 ± 0.55 s). Prediction of both outcomes using the dominant foot with LASSO resulted in a lower RMSE than the nondominant foot. Significance. These findings suggest that accelerometer-based unilateral foot tapping may serve as a fast, space efficient, and low-burden complement to conventional mobility assessments. Further validation in larger clinical populations and comparison with additional regression methods are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Engineering, University of British Columbia Okanagan, Kelowna, BC, Canada.
- Faculty of Health and Social Development, University of British Columbia Okanagan, Kelowna, BC, Canada.
- School of Health and Exercise Sciences, University of British Columbia Okanagan, Kelowna, BC, Canada.
ORCID-Profile: Shamim Noroozi, Jacquelyn Puckey, Jennifer M Jakobi
Förderung
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Noroozi, S., Puckey, J., Weyand, S., & Jakobi, J. M. (2026). Predicting gait and timed up and go time using foot-tapping test and accelerometer. Physiological Measurement, 47(8), 085004. https://doi.org/10.1088/1361-6579/ae8ca9
Vancouver
Noroozi S, Puckey J, Weyand S, Jakobi JM. Predicting gait and timed up and go time using foot-tapping test and accelerometer. Physiological Measurement. 2026;47(8):085004. doi:10.1088/1361-6579/ae8ca9
BibTeX
@article{Noroozi2026,
author = {Noroozi, Shamim and Puckey, Jacquelyn and Weyand, Sabine and Jakobi, Jennifer M},
title = {Predicting gait and timed up and go time using foot-tapping test and accelerometer},
journal = {Physiological Measurement},
year = {2026},
volume = {47},
number = {8},
pages = {085004},
doi = {10.1088/1361-6579/ae8ca9}
}
EUVIMED